Best oncologists in Milan: TOP 22 doctors

Professor Michele Reni is an experienced medical oncologist with over 30 years of practice based in Italy. He specializes in pancreatic adenocarcinoma, gastro-esophageal cancers, and central nervous system tumors. He has published over 180 papers on cancer treatment and is the coordinator of Italian Association of Medical Oncology (AIOM) guidelines for treatment and management of pancreatic cancer. He has also chaired numerous clinical trials on treating patients with metastatic pancreatic cancer.

Doctor Oreste Gentilini is an Italian specialist in breast cancer treatment with over 20 years of experience, providing over 5,000 breast cancer surgeries. He is the head of the Breast Unit in San Raffaele Hospital and the SOUND study at the European Institute of Oncology of Milan. He has authored over 100 papers on breast tumors treatment, with a focus on breast cancer management in young women and pregnant patients. He is a founding member and Vice President of EU-BREAST, and a member of the board of directors of the Italian National Association of Senologists and Surgeons (ANISC).

Prof. Montorsi is one of the top Italian experts in Urology and Andrology, with numerous scientific awards and 8,000+ urology/andrology surgeries. He directs the Urological Research Institute (URI) in Italy, is recognized among the most influential researchers of the past decade, and has developed his vein patching method to correct occlusive vein dysfunction. He is an Honorary Fellow of the Royal College of Surgeons of England and has written over 1,000 papers. He is a member of various medical organizations.

Professor Pietro Mortini MD is a highly experienced Italian neurosurgeon who specializes in neuro- and radiosurgeries with a focus on minimally invasive spine and brain operations. He is a Visiting Professor at the George Washington University, has a degree in Otorhinolaryngology and Neurosurgery from the University of Milan and University of Verona, and has patented a method of manufacturing a device for regenerating biological tissues. He also provides research in microsurgical therapy of pituitary adenomas and radiosurgery for uveal melanoma and is a member of the Italian Society of the Cranial Base.

Professor Nadia Di Muzio is a Head of the Radiotherapy Department in the San Raffaele Research Hospital in Milan since 2008. She has a degree in general medicine and surgery and specialty in oncological radiotherapy from the University of Milan and has done an internship at the Department of Radiation Oncology in the University of Madison. Professor Di Muzio is an author of 200 studies in radiation oncology research and an advocate of high-precision hypofraction methods in the radical treatment of prostate tumors. She currently holds positions in the Italian Association of Medical Oncology, the Italian Society of Oncological Urology and the European Society for Radiotherapy and Oncology.

Dr. Giorgia Mangili is the Head of the Medical Gynecological Oncology Group at the San Raffaele Scientific Institute Hospital since 2002. She has a degree in general medicine and specialties in gynecology and obstetrics, oncology, and is an Associate and Professor in obstetrics and gynecology. She focuses her work on gynaecological oncology, rare gynaecological tumours, preservation of in oncology and cancer and pregnancy. She is a member of the European Organisation for Treatment of Trophoblastic Diseases, the European Society of Gynaecological Oncology, and the Italian Society of Gynecologic Oncology.

Professor Massimo Falconi is a gastrointestinal oncologist with over 30 years of experience specializing in pancreatic diseases. He practices at Ospedale San Raffaele in Milan and has led 3,600 surgeries, including distal, total, middle pancreatectomies , pancreatic resections, and enucleations. He is the Director of the Pancreatic Surgery and the Pancreas Translational and Clinical Unit at IRCCS Ospedale San Raffaele with international experience in Japan, Spain, Germany, and Sweden. Prof. Falconi has written over 330 articles and taken part in 350+ Italian and 220+ international conferences, and is a member of several organizations.

Associate Professor of Thoracic Surgery with European Board qualifications. Head of mini-invasive thoracic surgery unit, specializing in the treatment of lung and pleural diseases and mediastinal disorders. Member of Italian Society of Thoracic Surgery and Thoracic Endoscopy, as well as author of a monograph and over 200 scientific publications.

Professor Riccardo Rosati is the Head of the Gastrointestinal Surgery (GI) Department at the San Raffaele Research Hospital in Milan, Italy. He is a highly experienced surgeon with over 30 years of experience, having completed medical degrees in general medicine and general surgery, as well as specialization in thoracic surgery. He is a member of multiple surgical associations, and has written over 300 publications. His department treats approximately 2,000 surgical cases per year.

Orthopedic Surgeon

Professor Stefano Boriani is a world-renowned orthopedic surgeon and author of unique surgical staging system of spinal tumors and tumor resection techniques. He has performed over 3,000 surgical procedures, written over 430 research articles, and invented a carbon fiber system for tumor reconstruction. He is also a professor at the Post-Graduate School of Orthopaedics at the University of Bologna, and a honorary member of several spine societies. He is also the founder of a non-profit association in Mozambique which supports medical activities and trains local surgeons.

Orthopedist, Oncologist, Specialist in osteosarcoma treatment

Professor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.

He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977. 

In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa. 

Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University. 

Current Positions: 

• .Since 1997, he is the Director of the Department of Medical Oncology and Haematology, at Istituto Clinico Humanitas, Milan. Also, he is Member of the Ethics Committee of Istituto Clinico Humanitas and Director of Clinical Research in the same Institute since 2007.
• - Since 2008, he is Member of the Planning Committee, Ministry of Work and of Health and Social Politics, Rome, Italy.
• - Since October 2008, Professor Santoro is Counsellor of the Board of Directors of the Fondazione Humanitas for Research of Rozzano, Italy.
• - Since November 2008, he is Expert Member of the National Centre for the Prevention and Control of Disease, Ministry of Work and of Health and Social Politics (Rome, Italy).
• - Since February 2009, he is National Representative preparatory actions for the "European Partnership for Action against Cancer" Ministry of Work and of Health and Social Politics (Rome, Italy).
• - Since February 2009, Professor Santoro is member of National Italian Committee on the Research Network in Oncology, Ministry of Work and of Health and Social Politics (Rome, Italy).
• - Since May 2009, he is Coordinator of the Oesophageal-Stomach Cancer Group Coordinator of the Liver and Biliary Tree Cancer Group, Regional Oncology Commission – Lombardy Oncology Network.

In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009). 

Publications: santoro%a - Search Results - PubMed (nih.gov) 

Filippo de Marinis is the Director of the Thoracic Oncology Unit at the European Centre for Oncology (Milan, Italy). The doctor leads clinical trials of new methods in the treatment of malignant tumors of the chest organs.

The doctor's experience is more than 30 years.

In 1978, De Marinis completed his studies in Pulmonology at the Sapienza University of Rome. From 1983 to 1986, he specialized in oncology at the Catholic University of the Sacred Heart in Rome. Filippo De Marinis then worked as a physician at the Carlo Forlanini Hospital and the Institute for Clinical Trials and Pneumophysiological Research. Since 2007, he has taught pulmonology at the Campus Biomedico private university in Rome and at the Sapienza University of Rome. Since 2013, the professor has been head of the Thoracic Cancer Unit at the European Oncology Center.

Doctor's appointment

An appointment with Filippo de Marinis lasts from 40 to 60 minutes. During this time, the doctor collects the patient's medical history and compares it with the examination results. In order to establish an accurate diagnosis or plan an operation, the doctor will prescribe additional tests if necessary.

Scientific activity

Professor de Marinis is the author of 250 scientific publications in 130 medical journals. As one of the leading experts in the treatment of lung cancer, he has spoken at 300 scientific congresses over the past 5 years.

The doctor participates in national and international clinical trials of new drugs.

Membership in organizations

• AIOT - Italian Thoracic Oncology Association;
• ESMO - European Society for Medical Oncology;
• ASCO - American Society of Clinical Oncology;
• IASLC - International Association for the Study of Lung Cancer;
• ETOP - European Thoracic Oncology Platform.

Barbara Alicia Jerechek is the Director of the Radiotherapy Unit at the European Oncology Centre in Milan and Professor of Radiation Oncology at the University of Milan. The doctor specializes in radiotherapy for all types of cancer and metastatic tumors.

• 26 years of experience in radiotherapy;
• 140 scientific publications.

Professor Jereczek received her medical degree from the University of Gdansk (Poland) in 1992. She completed advanced training in radiation oncology at the Warsaw Cancer Institute, the University of Milan, and the Beatson Cancer Centre at the University of Glasgow (UK). Since 1997, the doctor has been working as a radiotherapy specialist at the European Cancer Centre. Since 2015, she has been the head of the radiotherapy department at the clinic.

Doctor's appointment

An appointment with Dr. Erechek to plan radiation therapy takes 30-50 minutes. The doctor reviews the patient's medical records and test results. She explains the diagnosis and talks about how further treatment will proceed. The doctor gives recommendations on how best to prepare for the course of procedures so that they are as comfortable as possible.

To get a consultation with Professor Erechek, leave a request on the Bookimed website. A coordinating doctor will contact you to agree on the date and time of the consultation.

Scientific activity

Professor Barbara Alicia Ereczek is the author of 140 scientific publications.

Professional achievements and awards

Between 1999 and 2003, Professor Jereczek received 4 awards from the Medical University of Gdansk for scientific research in the field of oncology and radiotherapy.

Membership in organizations

• ESTRO - European Society for Therapeutic Radiology and Oncology;
• AIRO - Italian Society of Radiation Oncology;
• Protocol Review Committee of the European Institute of Oncology, Milan, Italy;
• Clinical Trials Quality Committee of the European Institute of Oncology, Milan, Italy.

Surgeon, senologist

Oncologist-urologist

Dr. Giuseppe Curigliano is the head of the Division of Early Drug Development at the European Institute of Oncology and an Associate Professor of Medical Oncology at the University of Milano in Italy. He is the founding member and scientific chair for the International Cardio-Oncology Society (ICOS) and has received the first ESO Umberto Veronesi Award in Vienna in 2017 and the Fellowship of the European Academy of Cancer Sciences in Paris in 2017.